Theravance Biopharma, Inc.

TBPH

—

Advanced chart & tools →

Theravance Biopharma, Inc.TBPH

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$2.06

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$107.46M

Net income

$105.89M

Net margin

98.5%

Gross margin

—

Dividends & financials

Theravance Biopharma, Inc. (TBPH) reported revenue of $107.46M and net income of $105.89M, or $2.06 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.